跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
WELLVONE Atovaquone 750mg/5mL oral liquid suspension bottle - TGA Drug Approval Details
Approvals
/
TGA
/
WELLVONE Atovaquone 750mg/5mL oral liquid suspension bottle
Approved
STANDARD
WELLVONE Atovaquone 750mg/5mL oral liquid suspension bottle
Aspen Pharmacare Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
70de6999c66d8fec
Company
Aspen Pharmacare Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
70de6999c66d8fec
Product Name
WELLVONE Atovaquone 750mg/5mL oral liquid suspension bottle
Artg Id
66688
Artg Name
WELLVONE Atovaquone 750mg/5mL oral liquid suspension bottle
Sponsor
Aspen Pharmacare Australia Pty Ltd
Company Detail Path
/organization/aspen-pharmacare-australia-pty-ltd
Artg Date
1998-12-07
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/fd02655bb750ff969654f73f02284921.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/e20146aa467021294d20e03d04041749.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
70de6999c66d8fec
Type
Standard
Back to TGA Approvals